PATENT CLAIM ANALYSIS

Application Number: 15886024
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "310000"]

Abstract:
Disclosed are solid state forms of Netarsudil mesylate, processes for preparation thereof, uses thereof, and pharmaceutical compositions thereof.

Claim (Index 10):
A method of treating glaucoma or ocular hypertension, comprising administering a therapeutic effective amount of crystalline form N7 of Netarsudil mesylate according to  claim 1  to a subject suffering from glaucoma or ocular hypertension, or otherwise in need of the treatment.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 88.0
- Lexical Diversity: 1.22222
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16315816', '15756719', '14412039', '16084357', '11796573']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.728249469671299
- 35 USC 102 Novelty (BERT): 0.5031369262748873
- Combined Prediction Score: 0.7057382153316578
- Mean Citation Score: 241.861148
- Max Citation Score: 249.31453
- Similarity Product: 188.9876696103537

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test